Engineering Probiotics to Sense and Treat Gut Disease

A Conversation with Dr. David Riglar By Ryan L. Cross Inflammatory bowel disease affects over one million Americans and directly costs patients over six billion dollars a year. Current treatments manage the disease with variable success, and diagnosis requires invasive and sometimes inaccurate procedures like colonoscopies.  But David Riglar, a postdoctoral research fellow at Harvard […]

Read more "Engineering Probiotics to Sense and Treat Gut Disease"